Novo Nordisk A/S ADR | Ownership
Companies that own Novo Nordisk A/S ADR
Loomis, Sayles & Co. LP
21,285,063
1.11%
-740,050
1.96%
06/30/2018
Renaissance Technologies LLC
19,142,300
1%
2,051,000
0.98%
06/30/2018
Fisher Asset Management LLC
13,569,671
0.71%
440,014
0.79%
06/30/2018
Managed Account Advisors LLC
7,386,206
0.39%
-150,390
0.15%
06/30/2018
Folketrygdfondet
5,693,949
0.3%
0
1.7%
06/30/2018
BlackRock Advisors LLC
5,239,296
0.27%
-550,624
0.23%
06/30/2018
SSgA Funds Management, Inc.
4,919,825
0.26%
-71,626
0.02%
06/30/2018
State Farm Investment Management Corp.
4,619,014
0.24%
0
0.28%
06/30/2018
Fayez Sarofim & Co.
4,496,960
0.24%
-144,498
1.12%
06/30/2018
Bank of America, NA (Private Banking)
4,491,515
0.24%
-80,412
0.15%
06/30/2018
| Address |
Novo Allé
Bagsværd CR 2880
Denmark
|
|
Employees
|
- |
| Website |
http://www.novonordisk.com |
| Updated |
07/08/2019 |
| Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following business segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. |
